ArticleThe American journal of medicine2023

The Prevention of COVID-19 in High-Risk Patients Using Tixagevimab-Cilgavimab (Evusheld): Real-World Experience at a Large Academic Center.

Mohanad M Al-Obaidi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.